Until recently TIMP-1 and HIF-1α (and in consequence miR-210) were seemingly totally un-related factors whose elevation is associated with bad prognosis for cancer patients (Zucker et al., 2000; Chan and Loscalzo, 2010; Wilczynski et al., 2011). This evidence concerns the gene TIMP1 and cancer.